Safety and Efficacy of Elbasvir/Grazoprevir in Patients With Hepatitis C Virus Infection and Compensated Cirrhosis: An Integrated AnalysisIra M. Jacobson, Barbara Haber, Cheng‐Yuan Peng et al.|Gastroenterology|2017Cited by 89
Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist TherapyJason Grebely, Heather Platt, Gregory J. Dore et al.|Annals of Internal Medicine|2022Cited by 20